Literature DB >> 3886645

Modification of histidines in human prothrombin. Effect on the interaction of fibrinogen with thrombin from diethyl pyrocarbonate-modified prothrombin.

F C Church, R L Lundblad, C M Noyes.   

Abstract

Diethyl pyrocarbonate (ethoxyformic anhydride) was used to modify histidyl residues in prothrombin. Diethyl pyrocarbonate inactivated the potential fibrinogen-clotting activity of prothrombin with a second-order rate constant of 70 M-1 min-1 at pH 6.0 and 25 degrees C. The difference spectrum of the modified protein had a maximum absorption at 240 nm which is characteristic of N-carbethoxyhistidine. The pH dependence for inactivation suggested the participation of a residue with a pKa of 6.2. Addition of hydroxylamine to ethoxyformylated prothrombin reversed the loss of fibrinogen-clotting activity. No structural differences were detected between the native and modified proteins using fluorescence emission and high-performance size-exclusion chromatography. The tyrosine and tryptophan content was not altered, but approximately 1-2 amino groups were modified. Statistical analysis of residual enzyme activity and extent of modification indicates that among 7 histidyl residues modified per molecule, there is 1 essential histidine (not in the active site) involved in the potential fibrinogen-clotting activity of prothrombin. To further examine its properties, the modified prothrombin was activated to thrombin using Echis carinatus venom protease. There was no difference in the catalytic activity of thrombin obtained from either native or ethoxyformylated prothrombin, as measured by H-D-Phe-pipecolyl-Arg-p-nitroanilide (D-Phe-Pip-Arg-NA) hydrolysis. However, thrombin produced from the modified protein showed a loss of fibrinogen-clotting activity but had a comparable apparent Ki value (about 20 microM) to thrombin from native prothrombin when fibrinogen was used as a competitive inhibitor during D-Phe-Pip-Arg-NA hydrolysis. The similarity in Ki values indicated that thrombin derived from diethyl pyrocarbonate-modified prothrombin does not have an altered fibrinogen-binding site. Although the histidyl residue involved during inactivation has not been identified, the results suggest that a histidyl residue in the thrombin portion of prothrombin is essential for interaction with fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886645

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Modification of uridine phosphorylase from Escherichia coli by diethyl pyrocarbonate. Evidence for a histidine residue in the active site of the enzyme.

Authors:  A K Drabikowska; G Woźniak
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

2.  Vitamin K2 (menaquinone) biosynthesis in Escherichia coli: evidence for the presence of an essential histidine residue in o-succinylbenzoyl coenzyme A synthetase.

Authors:  D K Bhattacharyya; O Kwon; R Meganathan
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

3.  Alternative methods for the determination of rate constants describing enzyme inactivation by an unstable inhibitor.

Authors:  C M Topham
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

4.  Suggestions on leading an academic research laboratory group.

Authors:  Frank C Church
Journal:  Open Life Sci       Date:  2022-06-15       Impact factor: 1.311

5.  Probing the role of active site histidine residues in the catalytic activity of lacrimal gland peroxidase.

Authors:  Abhijit Mazumdar; Debashis Bandyopadhyay; Uday Bandyopadhyay; Ranajit K Banerjee
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

6.  Evidence of an essential carboxyl residue in membrane-bound pyrophosphatase of Rhodospirillum rubrum.

Authors:  I Romero; H Celis
Journal:  J Bioenerg Biomembr       Date:  1992-12       Impact factor: 2.945

7.  Characterization of the type I dehydroquinase from Salmonella typhi.

Authors:  J D Moore; A R Hawkins; I G Charles; R Deka; J R Coggins; A Cooper; S M Kelly; N C Price
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.